 |
|
Taipei is not the place you go to complete big equity capital markets transactions, wherever you come from |
When Aslan Pharmaceuticals cast around for the right place to sell shares earlier this year, it did not choose Hong Kong, nor its hometown of Singapore, nor even mainland China’s two leading bourses, but Taiwan.
Aslan’s chief executive Carl Firth, a former head of Asia healthcare investment banking at Bank of America Merrill Lynch, was convinced it was the right decision.
Access this research
Enter your work email address to sign in or check whether your organisation already has access to Euromoney.
